Skip to content

Rivaroxaban-D4

Rivaroxaban-D4

Product Description
CAT No.
ALN-R017D01
CAS No.
1132681-38-9
Mol. F.
C19H14D4ClN3O5S
Mol. Wt.
439.9
Stock
Please Inquire
Chemical Name : 5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl-d4]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide
Smiles : O=C1N(C(C([2H])=C2[2H])=C(C([2H])=C2N(CCOC3)C3=O)[2H])C[C@H](CNC(C4=CC=C(Cl)S4)=O)O1
Inchi : InChI=1S/C41H56N4O11/c1-20-11-10-12-21(2)40(53)43-31-26(19-42-45-16-14-44(8)15-17-45)36(50)28-29(37(31)51)35(49)25(6)38-30(28)39(52)41(7,56-38)55-18-13-27(54-9)22(3)33(47)24(5)34(48)23(4)32(20)46/h10-13,18-20,22-24,27,32-34,46-51H,14-17H2,1-9H3,(H,43,53)/b11-10-,18-13-,21-12-,42-19+/t20-,22+,23+,24-,27-,32-,33+,34+,41-/m0/s1

Development and validation of stability indicating UPLC method for the determination of Rivaroxaban in bulk and finished products and identification of degradation products by LCMS

By Ali, Syed Mastan; Ramachandran, D.nFrom Journal of Applicable Chemistry (Lumami, India) (2021), 10(3), 291-301

Validated LC-MS/MS method for the determination of three genotoxic impurities in rivaroxaban drug substance

By Korlakunta, Vijaya Gouri; Dasari, Vijaya Bharathi; Sharma, Hemant Kumar; Nowduri, Annapurna; Bonige, Kishore Babu; Chavakula, Ramadas – From European Journal of Biomedical and Pharmaceutical Sciences (2020), 7(8), 492-500

Development of a stability-indicating HPLC method and a dissolution test for rivaroxaban dosage forms

By Souri, Effat; Mottaghi, Siavash; Zargarpoor, Mohammad; Ahmadkhaniha, Reza; Jalalizadeh, Hassan – From Acta Chromatographica (2016), 28(3), 347-361

Request For Quotation